Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Why You Shouldn’t Buy the Dip in Fastly Shares

By Thomas Niel, InvestorPlace Contributor

The easy money was made in FSLY stock, so don't buy this pullback. TikTok's risk may be overblown, but still take a 'wait-and-see' approach.

Steer Clear of Coronavirus Vaccine Also-Ran iBio Stock

By Thomas Niel, InvestorPlace Contributor

So, what's the play here? Too risky to go long (or short), stay far away vaccine play IBIO stock. Other vaccine candidates may offer opportunity. But, this "also-ran" isn't much of a contender.

Right Now, There’s No Point in Trying to Catch Falling Knife Genius Brands Stock

By Thomas Niel, InvestorPlace Contributor

But, chances are the company struggles to break into the media oligopoly. Instead, expect more dilution, as the company raises cash to keep the lights on. Barring a second round of the "Robinhood effect," expect GNUS stock to keep on tumbling from here.

Don’t Waste Your Time With Long-Shot Penny Stock Ocugen

By Thomas Niel, InvestorPlace Contributor

Recent news helps the odds for OCGN stock, but speculators have gotten carried away. Don't waste your time (or risk your capital) with this.

7 Value Stocks to Buy For Growth and Peace of Mind

By Thomas Niel, InvestorPlace Contributor

2020 has been great for growth stocks. But as markets reach premium valuations, consider these seven value stocks to buy for peace of mind.

Steer Clear of ‘Too Hot to Touch’ Wayfair Stock

By Thomas Niel, InvestorPlace Contributor

With more risks than catalysts, buying shares while they remain richly priced does not look like a strong proposition.

As Shares Lose Steam, Now’s the Time to Sell Nvidia Shares

By Thomas Niel, InvestorPlace Contributor

Granted, this winner has kept on winning so far in 2020, but NVDA stock may be topping out. Sell now, as shares remain near all-time highs.

All Bets Are Off With Novavax, So Tread Carefully

By Thomas Niel, InvestorPlace Contributor

With NVAX stock, it's debatable whether vaccine quality will be its advantage. At today's prices, take a wait-and-see approach.

After Vaccine Deal, Buy The Dip With Moderna Stock

By Thomas Niel, InvestorPlace Contributor

Those who bought MRNA stock may be cashing out. But with risk/return still in your favor, taking a small position may be worthwhile.

Hit the Brakes on Ford Stock for Now, But Buy It on Any Weakness

By Thomas Niel, InvestorPlace Contributor

Granted, F stock could rally in the next few years. But, in the short-term, it may be time to hit the brakes.

Load More